Spok Holdings, Inc. (SPOK)
USD 14.87
(-4.41%)
USD 14.87
(-4.41%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 26.29 Million USD | 49.04% |
| 2022 | 11.13 Million USD | 31.4% |
| 2021 | -629 Thousand USD | -61.4% |
| 2020 | -12.71 Million USD | 226.85% |
| 2019 | 2.28 Million USD | 46.63% |
| 2018 | 8.58 Million USD | -65.98% |
| 2017 | 22.33 Million USD | -41.25% |
| 2016 | 35.11 Million USD | -14.53% |
| 2015 | 39.07 Million USD | -7.0% |
| 2014 | 47.82 Million USD | -23.65% |
| 2013 | 61.64 Million USD | -6.4% |
| 2012 | 64.67 Million USD | -9.13% |
| 2011 | 86.94 Million USD | -11.14% |
| 2010 | 84.12 Million USD | -18.87% |
| 2009 | 99.92 Million USD | 108.5% |
| 2008 | -69.82 Million USD | -64.51% |
| 2007 | 132.37 Million USD | -8.89% |
| 2006 | 147.68 Million USD | -22.22% |
| 2005 | 175.8 Million USD | 29.99% |
| 2004 | 149.82 Million USD | -10.07% |
| 2003 | 166.6 Million USD | -27.35% |
| 2002 | 229.33 Million USD | 83.73% |
| 2001 | 124.82 Million USD | -53.17% |
| 2000 | 261.11 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 3.01 Million USD | 5.71% |
| 2024 Q2 | 5.88 Million USD | -7.8% |
| 2024 Q1 | 6.38 Million USD | 23.11% |
| 2023 Q1 | 5.7 Million USD | 0.85% |
| 2023 Q4 | 6.37 Million USD | -16.51% |
| 2023 Q3 | 7.63 Million USD | -0.81% |
| 2023 Q2 | 7.69 Million USD | 34.95% |
| 2023 FY | - USD | 49.04% |
| 2022 Q3 | 7.37 Million USD | 76.26% |
| 2022 Q4 | 5.65 Million USD | -23.3% |
| 2022 Q1 | 1.22 Million USD | -91.05% |
| 2022 Q2 | 4.18 Million USD | 240.64% |
| 2022 FY | - USD | 31.4% |
| 2021 Q3 | -1.04 Million USD | -169.61% |
| 2021 Q4 | 13.71 Million USD | 1410.32% |
| 2021 Q2 | 1.5 Million USD | 25.44% |
| 2021 Q1 | 1.19 Million USD | -95.79% |
| 2021 FY | - USD | -61.4% |
| 2020 FY | - USD | 226.85% |
| 2020 Q1 | -1.87 Million USD | -123.99% |
| 2020 Q2 | 5.23 Million USD | 378.84% |
| 2020 Q3 | 5.42 Million USD | 3.67% |
| 2020 Q4 | 28.47 Million USD | 425.0% |
| 2019 Q1 | 4.09 Million USD | 21.87% |
| 2019 FY | - USD | 46.63% |
| 2019 Q4 | 7.82 Million USD | 1775.54% |
| 2019 Q3 | 417 Thousand USD | 176.16% |
| 2019 Q2 | 151 Thousand USD | -96.31% |
| 2018 FY | - USD | -65.98% |
| 2018 Q4 | 3.35 Million USD | 28.53% |
| 2018 Q1 | 4.51 Million USD | -28.99% |
| 2018 Q3 | 2.61 Million USD | 142.43% |
| 2018 Q2 | 1.07 Million USD | -76.17% |
| 2017 FY | - USD | -41.25% |
| 2017 Q4 | 6.36 Million USD | 4.33% |
| 2017 Q1 | 4.6 Million USD | -57.18% |
| 2017 Q2 | 5.26 Million USD | 14.25% |
| 2017 Q3 | 6.1 Million USD | 15.95% |
| 2016 FY | - USD | -14.53% |
| 2016 Q4 | 10.75 Million USD | 15.87% |
| 2016 Q2 | 8.85 Million USD | -2.85% |
| 2016 Q1 | 9.11 Million USD | -25.48% |
| 2016 Q3 | 9.28 Million USD | 4.82% |
| 2015 FY | - USD | -7.0% |
| 2015 Q2 | 12.35 Million USD | 19.51% |
| 2015 Q1 | 10.34 Million USD | -4.02% |
| 2015 Q4 | 12.23 Million USD | 15.64% |
| 2015 Q3 | 10.57 Million USD | -14.4% |
| 2014 Q2 | 11.99 Million USD | -2.73% |
| 2014 FY | - USD | -23.65% |
| 2014 Q4 | 10.77 Million USD | -21.26% |
| 2014 Q1 | 12.33 Million USD | -33.27% |
| 2014 Q3 | 13.68 Million USD | 14.05% |
| 2013 Q4 | 18.48 Million USD | 32.58% |
| 2013 FY | - USD | -6.4% |
| 2013 Q1 | 16.09 Million USD | -24.75% |
| 2013 Q3 | 13.94 Million USD | -14.27% |
| 2013 Q2 | 16.26 Million USD | 1.02% |
| 2012 Q2 | 18.44 Million USD | -2.32% |
| 2012 FY | - USD | -9.13% |
| 2012 Q4 | 21.39 Million USD | 20.37% |
| 2012 Q3 | 17.77 Million USD | -3.63% |
| 2012 Q1 | 18.87 Million USD | -30.86% |
| 2011 Q2 | 21.45 Million USD | 20.99% |
| 2011 FY | - USD | -11.14% |
| 2011 Q1 | 17.73 Million USD | -14.7% |
| 2011 Q4 | 27.3 Million USD | 28.03% |
| 2011 Q3 | 21.32 Million USD | -0.59% |
| 2010 Q2 | 20.34 Million USD | -9.58% |
| 2010 Q3 | 19.86 Million USD | -2.34% |
| 2010 Q4 | 20.78 Million USD | 4.61% |
| 2010 Q1 | 22.5 Million USD | -4.53% |
| 2010 FY | - USD | -18.87% |
| 2009 Q2 | 24.12 Million USD | -16.51% |
| 2009 FY | - USD | 108.5% |
| 2009 Q1 | 28.89 Million USD | 160.01% |
| 2009 Q4 | 23.56 Million USD | -7.71% |
| 2009 Q3 | 25.53 Million USD | 5.84% |
| 2008 Q2 | 31.02 Million USD | 2.27% |
| 2008 Q1 | 30.33 Million USD | -12.8% |
| 2008 Q4 | -48.15 Million USD | -234.55% |
| 2008 Q3 | 35.79 Million USD | 15.38% |
| 2008 FY | - USD | -64.51% |
| 2007 Q4 | 34.78 Million USD | 1.71% |
| 2007 Q1 | 36.09 Million USD | -6.52% |
| 2007 Q2 | 32.6 Million USD | -9.67% |
| 2007 Q3 | 34.19 Million USD | 4.9% |
| 2007 FY | - USD | -8.89% |
| 2006 FY | - USD | -22.22% |
| 2006 Q2 | 38.66 Million USD | -0.65% |
| 2006 Q3 | 35.27 Million USD | -8.77% |
| 2006 Q4 | 38.6 Million USD | 9.45% |
| 2006 Q1 | 38.92 Million USD | -51.4% |
| 2005 Q2 | 32.58 Million USD | -26.97% |
| 2005 FY | - USD | 29.99% |
| 2005 Q1 | 44.62 Million USD | 7.54% |
| 2005 Q3 | 39.61 Million USD | 21.56% |
| 2005 Q4 | 80.08 Million USD | 102.18% |
| 2004 Q4 | 41.49 Million USD | 24.37% |
| 2004 Q3 | 33.36 Million USD | -11.13% |
| 2004 Q2 | 37.54 Million USD | -13.62% |
| 2004 Q1 | 43.46 Million USD | 0.0% |
| 2004 FY | - USD | -10.07% |
| 2003 FY | - USD | -27.35% |
| 2002 FY | - USD | 83.73% |
| 2001 FY | - USD | -53.17% |
| 2001 Q3 | -37.7 Thousand USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CareCloud, Inc. | -31.29 Million USD | 184.043% |
| Augmedix, Inc. | -17.68 Million USD | 248.73% |
| BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 92.476% |
| CareCloud, Inc. | -31.29 Million USD | 184.043% |
| HealthEquity, Inc. | 282.41 Million USD | 90.689% |
| iCoreConnect Inc. | -11.87 Million USD | 321.367% |
| Inovalon Holdings, Inc. | 186.56 Million USD | 85.904% |
| Nutex Health, Inc. | -14.58 Million USD | 280.347% |
| Omnicell, Inc. | 60.69 Million USD | 56.67% |
| OneMedNet Corporation | -11.97 Million USD | 319.677% |
| Progyny, Inc. | 64.46 Million USD | 59.207% |
| Renalytix Plc | -28.52 Million USD | 192.202% |
| Schrödinger, Inc. | -171.89 Million USD | 115.298% |
| Simulations Plus, Inc. | 6.13 Million USD | -328.919% |
| SOPHiA GENETICS SA | -70.7 Million USD | 137.195% |
| Streamline Health Solutions, Inc. | -12.81 Million USD | 305.189% |
| Ontrak, Inc. | -14.41 Million USD | 282.415% |
| GE HealthCare Technologies Inc. | 3.56 Billion USD | 99.261% |
| Sharecare, Inc. | -67.25 Million USD | 139.101% |
| Aclarion, Inc. | -4.14 Million USD | 735.13% |
| CareMax, Inc. | -590.46 Million USD | 104.454% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | 598.516% |
| Forian Inc. | 2.75 Million USD | -856.153% |
| Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | 598.516% |
| HeartBeam, Inc. | 675 Thousand USD | -3795.852% |
| GeneDx Holdings Corp. | -136.46 Million USD | 119.271% |
| SCWorx Corp. | -3.97 Million USD | 761.611% |
| Minerva Surgical, Inc. | -20.07 Million USD | 231.007% |
| Definitive Healthcare Corp. | -241.22 Million USD | 110.901% |
| 10x Genomics, Inc. | -205.11 Million USD | 112.821% |
| Zhongchao Inc. | -4.9 Million USD | 636.416% |
| Accolade, Inc. | -71.19 Million USD | 136.938% |
| MSP Recovery, Inc. | -69.22 Million USD | 137.99% |
| R1 RCM Inc. | 426.2 Million USD | 93.83% |
| Privia Health Group, Inc. | 27.18 Million USD | 3.256% |
| EUDA Health Holdings Limited | -8.3 Million USD | 416.818% |
| TruBridge, Inc. | -15.39 Million USD | 270.86% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 92.476% |
| Sharecare, Inc. | -67.25 Million USD | 139.101% |
| Health Catalyst, Inc. | -66.46 Million USD | 139.567% |
| GoodRx Holdings, Inc. | 108.82 Million USD | 75.835% |
| Premier, Inc. | 286.08 Million USD | 90.808% |
| HealthStream, Inc. | 59.58 Million USD | 55.868% |
| Certara, Inc. | 23.84 Million USD | -10.288% |
| GeneDx Holdings Corp. | -136.46 Million USD | 119.271% |
| Ontrak, Inc. | -14.41 Million USD | 282.415% |
| SHL Telemedicine Ltd. | 3.28 Million USD | -700.88% |
| CareCloud, Inc. | -31.29 Million USD | 184.043% |
| EUDA Health Holdings Limited | -8.3 Million USD | 416.818% |
| HeartBeam, Inc. | 675 Thousand USD | -3795.852% |
| Mangoceuticals, Inc. | -9.18 Million USD | 386.225% |
| CareMax, Inc. | -590.46 Million USD | 104.454% |
| Healthcare Triangle, Inc. | -4.1 Million USD | 740.765% |
| National Research Corporation | 45.98 Million USD | 42.814% |
| Aclarion, Inc. | -4.14 Million USD | 735.13% |
| OptimizeRx Corporation | -21.3 Million USD | 223.411% |